The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT01068093

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01068093
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01068093. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome
Intervention (Drug)
Ezetimibe
Lead sponsor
Yokohama City University Medical Center (class: other)

Record details

Record id
cardio:ct-nct01068093
Content hash
76176eef0c6914dba4e6559e5b61c3bea1a6743870014387e8a576285efa2724